Authors
Latest:
Provider status: Important to pharmacists, critical to patientsValidation through inclusion in Medicare Part B could lead to recognition of pharmacists as healthcare providers across the board.
Latest:
Pathways through pharmacy: Bob, the Pharmacy Man!Bob Benton's life in pharmacy has brought him satisfaction and enjoyment of his profession. And he's done a lot of people a lot of good.
Latest:
Health System Specialty Pharmacies Enhance Services and SavingsBy 2020, industry experts believe specialty drugs will account for 50% of U.S. spending on pharmaceuticals.
Latest:
Why I filed a class action lawsuit against WalmartCalifornia pharmacist Afrouz Nikmanesh recently filed a class-action lawsuit against Walmart, alleging the retail giant cheated her and her colleagues out of work breaks and overtime pay.
Latest:
Pharma needs to refocus on what matters mostThree of the most heavily invested players in the pharmaceutical industry are at odds. Pharma manufacturers need to recoup R&D costs and demonstrate accountability to leadership and shareholders, keeping drug prices as high as possible before their patents expire. PBMs are responsible for driving down costs for their plan sponsors, frequently engaging in hard negotiations with manufacturers. Pharmacists are often afterthoughts to the conversation, even though they are arguably the healthcare providers with more ability to influence patient outcomes and maximize the value of high-cost medication therapies than any other member of the care continuum.
Latest:
Provider status is fine and dandy, but pharmacists need to get paidIn the pharmacist's hierarchy of needs, which comes first? Provider status? Or getting paid for the work you're doing right now?
Latest:
Prevent Rx drug abuse: Lock up those medsWhat if pharmacies give a lockbox to every patient taking a controlled medication? This project aims to find out.
Latest:
Does your pharmacy comply with quality assurance requirements?Some tips on what constitutes a QA and how to comply with pharmacy law when creating one.
Latest:
For patient-focused attention, call a clinical pharmacistAdding pharmacists to the care team will result in better patient outcomes, lower payer costs, relief for physicians, and better use of pharmacists' skills and experience. It's a no-brainer.
Latest:
Prescription Drug Monitoring Programs Benefit PharmacistsHow PDMPs are helping both patients and pharmacists.
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Rivaroxaban for inherited thrombophilia: A case studyIs rivaroxaban the best therapeutic option for this patient?
Latest:
Job tips for pharmacy grads, 2015Looking for that first pharmacy job? Here are a few things to keep in mind.
Latest:
Edoxaban approved to prevent AF stroke and treat VTEEdoxaban is an oral factor Xa inhibitor that prevents thrombin generation and platelet aggregation, and therefore thrombus formation.
Latest:
Cost vs. value: Healthcare shifts its focusValue-based care is transforming the world of healthcare. Simple cost management must give way to utilization management, and alignment of stakeholder services is inevitable.
Latest:
Pharmacists and unionization: It’s later than you thinkPharmacists need to unionize. You've heard all the reasons. Here's another one -- and it's time-sensitive.
Latest:
Pharmacists on the frontline of preventive healthcare servicesFor patients, preventive services are a vital healthcare resource. For the healthcare delivery system, they produce cost savings. Pharmacists are a key link.
Latest:
FDA approves ceftazidime-avibactam to treat two complicated infectionsThe combination product is indicated to treat either complicated intra-abdominal infections, where it is used in combination with metronidazole, or complicated urinary tract infections in patients with few or no other treatment options.
Latest:
Pharmaceuticals and pharmaphobesIt can take years to establish the safety and efficacy of new drug therapies. What should we do in the meantime?
Latest:
15 keys to the New PharmacyIn Part 3 of "The New Pharmacy," Mark Burger takes you through the daily checklist of a successful practice.
Latest:
The market side of biosimilarsR&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.
Latest:
FDA approves PAH treatmentSelexipag is a first-in-class oral treatment option to reduce progression and hospitalization for pulmonary arterial hypertension.
Latest:
Sterile compounding: Regulations, best practices, and industry standardsWhere things stand, where they're headed, and what you need to do now.
